药物发现资讯学市场规模、份额、成长分析、按功能、按应用、按解决方案、按最终用户、按地区 - 行业预测，2025 年至 2032 年

2023 年全球药物发现资讯学市场规模价值 32.9 亿美元，预计将从 2024 年的 36.6 亿美元增长到 2032 年的 86.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.3%。

由于生物技术和製药公司加大对研究的投入，以及对罕见疾病治疗和罕见疾病药物开发的需求不断增长，全球药物发现资讯学市场正在经历显着增长。研究支出的激增凸显了资料管理在药物研发中的关键作用，而广泛的药物和化合物资料库对于药物研究至关重要。现代资讯学受到高效能运算和线上服务的推动，采用先进的软体进行有效的资料处理、管理和分析。此外，对药物开发的日益关注、对新型治疗药物的需求不断增加以及In Silico分析的广泛使用进一步推动了市场扩张。然而，虽然与资讯工具相关的高成本可能会阻碍成长，开发中国家新兴的生物技术领域仍存在着有利可图的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 专利分析

药物发现资讯学市场规模（依功能划分）

• 市场概况
• 定序和目标资料分析
• 对接
• 分子建模
• 准备库和资料库
• 其他功能

药物发现资讯学市场规模（按应用）

• 市场概况
• 药物研发
• 药物开发
  • 临床前研究
  • 临床试验

药物发现资讯学市场规模（按解决方案）

• 市场概况
• 软体
• 服务

药物发现资讯学市场规模（按最终用户划分）

• 市场概况
• 製药公司
• 生技公司
• 业务研究组织（CRO）
• 其他最终用户

药物发现资讯学市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• IBM（United States）
• Infosys Limited（India）
• Thermo Fisher Scientific（United States）
• PerkinElmer Inc.（United States）
• Schrodinger, Inc.（United States）
• Charles River Laboratories International, Inc.（United States）
• Certara, Inc.（United States）
• Accenture plc（Ireland）
• Agilent Technologies, Inc.（United States）
• Illumina, Inc.（United States）
• Dassault Systemes SE（France）
• Collaborative Drug Discovery, Inc.（United States）
• Eurofins DiscoverX Products（United States）
• Jubilant Biosys Limited（India）
• Selvita SA（Poland）
• Novo Informatics Pvt. Ltd.（India）
• ChemAxon Ltd.（Hungary）
• Albany Molecular Research Inc.（United States）
• Boehringer Ingelheim GmbH（Germany）
• Oracle Corporation（United States）

结论和建议

Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global drug discovery informatics market is witnessing significant growth driven by rising demand for rare illness treatments and orphan drug development, alongside enhanced research investment by biotechnology and pharmaceutical companies. This surge in research expenditure highlights the vital role of data management in drug discovery, where extensive databases of drugs and compounds are essential for pharmaceutical research. Modern informatics employs advanced software for effective data processing, management, and analysis, supported by improvements in high-performance computing and online services. Additionally, the growing focus on drug development, increasing need for new therapeutics, and widespread adoption of in silico modeling technology further propel market expansion. However, the high costs associated with informatics tools may hinder growth, while emerging biotech sectors in developing nations present lucrative opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segments Analysis

Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Informatics Market

The global drug discovery informatics market is significantly propelled by the swift developments in technology, especially in artificial intelligence (AI) and machine learning (ML). These innovations enhance data analysis capabilities, enabling researchers to process vast amounts of information swiftly and accurately. This increased efficiency not only streamlines the identification of molecular candidates for drug development but also expedites the overall drug discovery process. By harnessing powerful algorithms and predictive analytics, AI and ML are revolutionizing how pharmaceutical companies approach drug development, thereby driving the growth of the drug discovery informatics market on a global scale.

Restraints in the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market faces significant obstacles due to concerns surrounding data protection and the necessity to adhere to legal regulations. Compliance with privacy laws, such as the General Data Protection Regulation (GDPR), complicates the management and sharing of critical information. As a result, these regulatory challenges hinder research efforts and create barriers that limit the adoption of advanced informatics technologies by companies. Consequently, this situation stifles innovation and growth within the market, making it increasingly difficult for organizations to leverage new insights and capabilities essential for advancing drug discovery processes on a global scale.

Market Trends of the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market is witnessing a significant trend towards the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. This shift is revolutionizing the industry by enhancing data analysis capabilities, expediting the identification of potential drug candidates, and leveraging predictive modeling to streamline the drug discovery process. As a result, pharmaceutical companies and research institutions are experiencing heightened creativity and operational efficiency, driving the demand for advanced informatics solutions. This trend indicates a transformative approach to drug discovery, promising more innovative therapies and faster time-to-market, thus positioning AI and ML as pivotal elements in the future of pharmacological research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Drug Discovery Informatics Market Size by Function & CAGR (2025-2032)

• Market Overview
• Sequencing and Target Data Analysis
• Docking
• Molecular Modelling
• Library & Database Preparation
• Other functions

Global Drug Discovery Informatics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Drug Development
  • Preclinical Testing
  • Clinical Trials

Global Drug Discovery Informatics Market Size by Solution & CAGR (2025-2032)

• Market Overview
• Software
• Services

Global Drug Discovery Informatics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organization (CROs)
• Other End Users

Global Drug Discovery Informatics Market Size & CAGR (2025-2032)

• North America (Function, Application, Solution, End User)
  • US
  • Canada
• Europe (Function, Application, Solution, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Function, Application, Solution, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Function, Application, Solution, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Function, Application, Solution, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IBM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collaborative Drug Discovery, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Biosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Informatics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChemAxon Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albany Molecular Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations